BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua H, Kong Q, Yin J, Zhang J, Jiang Y. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy. J Hematol Oncol 2020;13:64. [PMID: 32493414 DOI: 10.1186/s13045-020-00904-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78. [PMID: 35273164 DOI: 10.1038/s41392-022-00925-z] [Reference Citation Analysis]
2 Zhu J, Simayi N, Wan R, Huang W. CAR T targets and microenvironmental barriers of osteosarcoma. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.12.010] [Reference Citation Analysis]
3 Yang S, Zhang H, Yang H, Zhang J, Wang J, Luo T, Jiang Y, Hua H. SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion. Exp Hematol Oncol 2021;10:17. [PMID: 33622411 DOI: 10.1186/s40164-021-00212-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Koo H, Byun S, Seo J, Jung Y, Lee DC, Cho JH, Park YS, Yeom YI, Park KC. PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia. Cancers (Basel) 2021;13:3850. [PMID: 34359752 DOI: 10.3390/cancers13153850] [Reference Citation Analysis]
5 Ngo MT, Jeng HY, Kuo YC, Diony Nanda J, Brahmadhi A, Ling TY, Chang TS, Huang YH. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. Int J Mol Sci 2021;22:1931. [PMID: 33669204 DOI: 10.3390/ijms22041931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest 2021. [PMID: 34417736 DOI: 10.1007/s40618-021-01663-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Raza M, Kumar N, Nair U, Luthra G, Bhattacharyya U, Jayasundar S, Jayasundar R, Sehrawat S. Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy. Mol Cell Biochem 2021;476:3271-84. [PMID: 33886058 DOI: 10.1007/s11010-021-04149-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Niu M, Yi M, Li N, Wu K, Wu K. Advances of Targeted Therapy for Hepatocellular Carcinoma. Front Oncol 2021;11:719896. [PMID: 34381735 DOI: 10.3389/fonc.2021.719896] [Reference Citation Analysis]
9 Zhang H, Yang S, Wang J, Jiang Y. Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1738. [PMID: 33917483 DOI: 10.3390/cancers13071738] [Reference Citation Analysis]
10 Storz MA, Ronco AL. Quantifying dietary acid load in U.S. cancer survivors: an exploratory study using NHANES data. BMC Nutr 2022;8:43. [PMID: 35505426 DOI: 10.1186/s40795-022-00537-4] [Reference Citation Analysis]
11 Huang HS, Chu SC, Chen PC, Lee MH, Huang CY, Chou HM, Chu TY. Insuline-Like Growth Factor-2 (IGF2) and Hepatocyte Growth Factor (HGF) Promote Lymphomagenesis in p53-null Mice in Tissue-specific and Estrogen-signaling Dependent Manners. J Cancer 2021;12:6021-30. [PMID: 34539876 DOI: 10.7150/jca.60120] [Reference Citation Analysis]
12 Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Salinas PS, Chaparro M, Gómez-Lahoz AM, Zoullas S, Rodríguez-Torres R, Román ID, Monasor LS, Ruiz-Llorente L, Del Carmen Boyano-Adánez M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Acosta MB, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B, On Behalf Of The Predicrohn Study Group From Geteccu. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. Biomed Pharmacother 2021;144:112239. [PMID: 34601192 DOI: 10.1016/j.biopha.2021.112239] [Reference Citation Analysis]
13 Yang S, Yang S, Zhang H, Hua H, Kong Q, Wang J, Jiang Y. Targeting Na+ /K+ -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma. Br J Pharmacol 2021. [PMID: 34233013 DOI: 10.1111/bph.15616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 [DOI: 10.12998/wjcc.v10.i11.3321] [Reference Citation Analysis]
15 Ali R, Huwaizi S, Alhallaj A, Al Subait A, Barhoumi T, Al Zahrani H, Al Anazi A, Latif Khan A, Boudjelal M. New Born Calf Serum Can Induce Spheroid Formation in Breast Cancer KAIMRC1 Cell Line. Front Mol Biosci 2021;8:769030. [PMID: 35004846 DOI: 10.3389/fmolb.2021.769030] [Reference Citation Analysis]
16 Chen D, Li H, Zhao Q, Song J, Lin C, Yu J. Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naïve first-episode schizophrenia. Psychiatry Res 2021;297:113717. [PMID: 33503523 DOI: 10.1016/j.psychres.2021.113717] [Reference Citation Analysis]
17 Liu Y, Nelson MV, Bailey C, Zhang P, Zheng P, Dome JS, Liu Y, Wang Y. Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor. Oncogene 2021;40:4809-19. [PMID: 34155347 DOI: 10.1038/s41388-021-01907-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Li S, Liu F, Zheng K, Wang W, Qiu E, Pei Y, Wang S, Zhang J, Zhang X. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Mol Cancer 2021;20:161. [PMID: 34876132 DOI: 10.1186/s12943-021-01453-0] [Reference Citation Analysis]
19 Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol 2020;9:32. [PMID: 33292604 DOI: 10.1186/s40164-020-00191-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
20 Mancarella C, Morrione A, Scotlandi K. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options. Cells 2021;10:2075. [PMID: 34440844 DOI: 10.3390/cells10082075] [Reference Citation Analysis]
21 Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma MM, Kuni RAT, Abdelmajid A, Abdelhafez I, Arif R, Mulhim M, Abukhattab M, Dar SR, Moustafa AA, Elkord E, Al Khal AL, Elzouki AN, Cyprian F. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity. Vaccines (Basel) 2021;9:1056. [PMID: 34696164 DOI: 10.3390/vaccines9101056] [Reference Citation Analysis]
22 Agarwal NK, Kim CH, Kunkalla K, Vaghefi A, Sanchez S, Manuel S, Bilbao D, Vega F, Landgraf R. Smoothened (SMO) regulates insulin-like growth factor 1 receptor (IGF1R) levels and protein kinase B (AKT) localization and signaling. Lab Invest 2021. [PMID: 34893758 DOI: 10.1038/s41374-021-00702-6] [Reference Citation Analysis]
23 Duan X, Wang W, Pan Q, Guo L. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development. Front Oncol 2021;11:730038. [PMID: 34485159 DOI: 10.3389/fonc.2021.730038] [Reference Citation Analysis]
24 Mansour MA, Caputo VS, Aleem E. Highlights on selected growth factors and their receptors as promising anticancer drug targets. Int J Biochem Cell Biol 2021;140:106087. [PMID: 34563698 DOI: 10.1016/j.biocel.2021.106087] [Reference Citation Analysis]
25 Sottoriva K, Pajcini KV. Notch Signaling in the Bone Marrow Lymphopoietic Niche. Front Immunol 2021;12:723055. [PMID: 34394130 DOI: 10.3389/fimmu.2021.723055] [Reference Citation Analysis]
26 Moon H, Ro SW. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3026. [PMID: 34204242 DOI: 10.3390/cancers13123026] [Reference Citation Analysis]
27 Grega T, Vojtechova G, Gregova M, Zavoral M, Suchanek S. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia. Physiol Res 2021;70:509-22. [PMID: 34062073 DOI: 10.33549/physiolres.934631] [Reference Citation Analysis]